Bioquell plc Rating Lowered to Hold at N+1 Singer (BQE)
Bioquell plc (LON:BQE) was downgraded by N+1 Singer to a “hold” rating in a research note issued on Friday, StockRatingsNetwork.com reports. They currently have a GBX 112 ($1.89) price target on the stock, down from their previous price target of GBX 157 ($2.64). N+1 Singer’s price objective would indicate a potential upside of 5.16% from the company’s current price.
Bioquell plc (LON:BQE) traded up 0.47% during mid-day trading on Friday, hitting GBX 106.50. The stock had a trading volume of 23,427 shares. Bioquell plc has a 52 week low of GBX 120.50 and a 52 week high of GBX 154.00. The stock has a 50-day moving average of GBX 124.9 and a 200-day moving average of GBX 135.1. The company’s market cap is £45.2 million.
A number of other analysts have also recently weighed in on BQE. Analysts at Investec reiterated a “hold” rating on shares of Bioquell plc in a research note on Thursday. Separately, analysts at Nplus1 Brewin reiterated a “buy” rating on shares of Bioquell plc in a research note on Thursday, March 20th. They now have a GBX 157 ($2.64) price target on the stock.
Bioquell PLC is a holding company. It is engaged in the principal activities of designing, manufacturing and supplying of bio-decontamination and containment equipment, related products and services to the healthcare, life sciences and defense industries, and testing, regulatory and compliance services to a range of companies, including the aerospace, telecoms and defense industries.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.